Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) Operating Margin (2023 - 2024)

Exousia Bio (LMMY) posted Operating Margin of 115.79% for Q3 2024, down 140.06% sequentially from 289.04% in Q2 2024.

Analysis

Exousia Bio (LMMY) Operating Margin (2023 - 2024) Analysis & Trends

Exousia Bio (LMMY) has 2 years of Operating Margin data on file, last reported at 115.79% in Q3 2024.

  • Quarterly Operating Margin changed N/A year-over-year to 115.79% in Q3 2024, while the trailing twelve-month figure through May 2025 was 25.68% (up 14739.0% YoY) and the FY2025 annual result came in at 465.73%, down 31386.0% from the prior year.
  • Operating Margin fell to 115.79% in Q3 2024 per LMMY's latest filing, from 289.04% in the prior quarter.
  • The five-year high for Operating Margin was 289.04% in Q2 2024, with the low at 224.39% in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 New Oriental Education & Technology 93.91 Bn 91.17 Bn 812.22 Mn 5.61%
2 Laureate Education 5.10 Bn 4.94 Bn 237.67 Mn 36.28%
3 Graham Holdings 4.76 Bn 3.51 Bn 777.03 Mn 6.42%
4 Covista 4.48 Bn 4.07 Bn 284.63 Mn 19.04%
5 Grand Canyon Education 3.95 Bn 3.67 Bn 204.08 Mn 22.02%
6 Stride 3.64 Bn 2.69 Bn 217.28 Mn 16.64%
7 McGraw Hill 2.53 Bn 2.33 Bn 439.20 Mn 20.78%
8 Perdoceo Education 2.06 Bn 751.01 Mn 162.46 Mn 25.72%
9 TAL Education 1.93 Bn -754.87 Mn 227.32 Mn -10.34%
10 Exousia Bio 368,824.87 368,824.87 -62,108.00 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2024 -115.79%
May 31, 2024 -151.71%
Feb 29, 2024 -224.39%
Nov 30, 2023 -192.21%